Dr. Reddy's launches generic Zemplar; Legislation would limit use of guns by FDA agents;

> Two senior Republican lawmakers have come out in favor of opposition by the generic drug industry to a proposed FDA rule that would have them change labels on products if they receive new safety information. Story

> The FDA has approved Dr. Reddy's generic version of Zemplar, the active version of vitamin D made by AbbVie ($ABBV). Story

> Michigan is looking at legislation to regulate compounding pharmacies. Item

> Oasmia Pharmaceutical AB has extended a production collaboration with Baxter's ($BAX) BioPharma Solutions for the Swedish pharmaceutical company products. Release

> The Philippines FDA has ordered the recall of all lots of a heparin-based blood thinner manufactured in India. Report

> The EU will require a new logo on all authorized online pharmacies that will link to a database of approved pharmacies to help consumers avoid counterfeits. Story

And Finally... Representative Chris Stewart (R-UT) is introducing legislation that would limit the use of guns by agents in departments like the FDA, saying they don't need to be "armed to the teeth." Story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.